THC
Tenet Healthcare Corporation NYSE$185.35
Mkt Cap $16.2B
52w Low $146.31
38.7% of range
52w High $247.21
50d MA $207.25
200d MA $197.01
P/E (TTM)
11.7x
EV/EBITDA
6.6x
P/B
1.9x
Debt/Equity
3.1x
ROE
4.6%
P/FCF
7.1x
RSI (14)
—
ATR (14)
—
Beta
1.50
50d MA
$207.25
200d MA
$197.01
Avg Volume
1.2M
About
Tenet Healthcare Corporation operates as a diversified healthcare services company. The company operates in three segments: Hospital Operations and Other, Ambulatory Care, and Conifer. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies. The company also provides intensive and critical care…
Recent Earnings
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 30, 2026 | TNS | 4.21 | 4.82 | +14.5% | 177.12 | +1.1% | +3.5% | — | — | — | — | — |
| Feb 11, 2026 | TNS | 4.07 | 4.70 | +15.5% | 226.35 | +0.0% | +2.6% | +2.1% | +3.5% | +2.4% | +0.8% | — |
| Oct 28, 2025 | TNS | 3.34 | 3.70 | +10.8% | 204.62 | +0.4% | +2.2% | +2.0% | +0.9% | -1.6% | +1.5% | — |
| Jul 22, 2025 | TNS | 2.87 | 4.02 | +40.1% | 155.97 | +1.2% | +1.5% | -4.9% | -1.9% | +0.4% | +0.1% | — |
| Apr 29, 2025 | TNS | 3.12 | 4.36 | +39.7% | 138.35 | -0.9% | +3.3% | +5.0% | +7.0% | +7.7% | +9.5% | — |
| Feb 12, 2025 | TNS | 2.95 | 3.44 | +16.6% | 126.19 | +1.4% | +5.8% | +5.6% | +6.9% | +7.5% | +8.8% | — |
| Oct 29, 2024 | TNS | 2.33 | 2.93 | +25.8% | 162.76 | -1.0% | -2.9% | -4.8% | -4.1% | -0.2% | +2.5% | — |
| Jul 24, 2024 | TNS | 1.90 | 2.31 | +21.6% | 145.34 | +0.6% | +3.0% | +4.3% | +5.2% | +3.3% | +3.0% | — |
| Apr 30, 2024 | TNS | 1.45 | 3.22 | +122.1% | 112.29 | +0.5% | +3.3% | +5.9% | +7.1% | +9.0% | +10.5% | — |
| Feb 8, 2024 | TNS | 1.60 | 2.68 | +67.5% | 89.02 | +0.3% | -1.0% | +1.7% | -1.1% | -1.2% | +1.0% | — |
Recent Analyst Ratings
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 1 | KeyBanc Capital Markets | Maintains | Overweight → Overweight | — | $177.12 | $179.11 | +1.1% | +3.5% | — | — | — | — |
| May 1 | Guggenheim | Maintains | Buy → Buy | — | $177.12 | $179.11 | +1.1% | +3.5% | — | — | — | — |
| May 1 | Wells Fargo | Maintains | Overweight → Overweight | — | $177.12 | $179.11 | +1.1% | +3.5% | — | — | — | — |
| May 1 | RBC Capital | Maintains | Outperform → Outperform | — | $177.12 | $179.11 | +1.1% | +3.5% | — | — | — | — |
| Mar 12 | Mizuho | Maintains | Outperform → Outperform | — | $234.58 | $233.09 | -0.6% | -4.2% | -3.0% | -6.5% | -9.8% | -13.4% |
| Mar 12 | Guggenheim | Maintains | Buy → Buy | — | $234.58 | $233.09 | -0.6% | -4.2% | -3.0% | -6.5% | -9.8% | -13.4% |
| Feb 20 | Leerink Partners | Maintains | Outperform → Outperform | — | $228.08 | $227.66 | -0.2% | +0.8% | +2.5% | +4.2% | +3.9% | +5.1% |
| Feb 17 | Truist | Maintains | Buy → Buy | — | $231.10 | $233.04 | +0.8% | +1.4% | +0.3% | -1.3% | -0.5% | +1.2% |
| Feb 13 | Guggenheim | Maintains | Buy → Buy | — | $232.26 | $231.16 | -0.5% | -0.5% | +0.9% | -0.2% | -1.8% | -1.0% |
| Feb 13 | Barclays | Maintains | Overweight → Overweight | — | $232.26 | $231.16 | -0.5% | -0.5% | +0.9% | -0.2% | -1.8% | -1.0% |
Recent Filings
8-K · 5.02
!!! Very High
Unknown — 8-K 5.02: Executive Change
A senior executive departure at Terraces Health Care (THC) creates immediate leadership uncertainty and potential operational disruption, warranting investor caution until succession clarity emerges.
Apr 10
8-K · 5.02
!!! Very High
Unknown — 8-K 5.02: Executive Change
A new executive hire with substantial sign-on incentives signals management transition and potential strategic shift, which investors should monitor for operational direction changes and whether this leader can drive shareholder value.
Mar 30
8-K · 7.01
! Medium
Unknown — 8-K 7.01: Regulation FD Disclosure
Without seeing the actual press release content, I cannot provide specific analysis; however, investors should review Exhibit 99.1 immediately to assess whether disclosed matters affect earnings guidance, operations, or competitive positioning.
Mar 12
8-K
Tenet Healthcare Corporation New -- 8-K Filing
Tenet Healthcare's 2025 net income fell 56% year-over-year to $1.407 billion despite management confidence in executing strategy and meeting full-year 2026 guidance.
Feb 11
8-K · 8.01
!! High
Tenet Healthcare Corporation New -- 8-K 8.01: Material Event / Announcement
Tenet Healthcare's agreement with Conifer Health and CommonSpirit Health reduces its balance sheet liabilities by approximately $885 million through a redeemable non-controlling interest reduction.
Feb 2
Data updated apr 27, 2026 4:40am
· Source: massive.com